Comorbidity of clinical symptoms of reflux disease with lipid-metabolic parameters in Yakuts
https://doi.org/2510.25789/YMJ.2019.65.24
Abstract
An assessment of the association of the clinical manifestations of reflux disease with lipid-metabolic parameters in individuals of the Yakut nationality was carried out. The study revealed the contribution of components of metabolic syndrome, in particular abdominal obesity, arterial hypertension and triglycerides, to the development of dyspeptic symptoms, such as bloating, heaviness in the epigastrium, esophageal (belching) and out-of-esophageal manifestations (night cough) of reflux disease.
Keywords
About the Authors
A. S. AsekritovaRussian Federation
Asekritova Alexandra S. – PhD, Senior Lecturer of Internal Medicine and General Practice (Family Medicine) Faculty of Postgraduate Medical Education
the Republic of Sakha (Yakutia), 677000, Yakutsk, Belinsky str., 58
E. S. Kylbanova
Russian Federation
Kylbanova Elena S. – MD, Head of Internal Medicine and General Practice ( Family Medicine ) Faculty of Postgraduate Medical Education
the Republic of Sakha (Yakutia), 677000, Yakutsk, Belinsky str., 58
References
1. Asekritova A.S. Gastroesophageal reflux disease in combination with metabolic syndrome in Yakutia residents / A.S. Asekritova, E.S. Kylbanova, E.A. Emelianova // Yakut Medical Journal. – 2015. – №1. – р.6-8.
2. Asekritova A.S. Lipid-metabolic risk factors for chronic non-communicable diseases in individuals with gastroesophageal reflux disease / A.S. Asekritova, E.S. Kylbanova // Ateroskleroz. – 2015. – №3. – р.63-71.
3. Bondarenko E.Yu. Clinical endoscopic and morphological features of GERD in patients with abdominal obesity: PhD thesis abstract / E.Y. Bondarenko. – M.. 2010. – 23 c.
4. Kachina A.A. Gastroesophageal reflux disease and obesity: chronobiological indicators of the cardiovascular system and cardiovascular risk factors: PhD thesis abstract: 14.01.04 / A.A. Kachina. – Perm, 2013. – 18 s.
5. Kseneva S.I. Clinical features of gastroesophageal reflux disease in overweight patients / S.I. Kseneva, E.V. Borodulina, V.V. Udut // Collection of theses of the XIII National Congress of Physicians. – M., 2018. – р. 153-154.
6. Khlynova O.V. The problem of comorbidity, taking into account the state of the cardiovascular system in patients with arterial hypertension and acid-related diseases / O.V. Khlynova, A.V. Tuyev, L.N. Beresneva, A.V. Agafonov // Kazan Medical Journal. – 2013. – №1. – р. 80-85.
7. Abdominal Visceral to Subcutaneous Adipose Tissue Ratio Is Associated with Increased Risk of Erosive Esophagitis / EY Ze, BJ Kim, H Kang, JG Kim // Dig Dis Sci. – 2017. – V.62(5). – P.1265-1271. doi: 10.1007/s10620-017-4467-4
8. Metabolic syndrome in relation to Barrett’s esophagus and esophageal adenocarcinoma: Results from a large population-based casecontrol study in the Clinical Practice Research Datalink / J Drahos, L Li, SS Jick, MB Cook // Cancer Epidemiol. – 2016. – V.42 (9). doi: 10.1016/j.canep.2016.02.008.
9. Obesity increases the risk of erosive esophagitis but metabolic unhealthiness alone does not: a large-scale cross-sectional study / M.K. Baeg, S.H. Ko, S.Y. Ko [et al.] // BMC Gastroenterol. – 2018. – V.18 (82). doi:10.1186/s12876-018-0814-y.
10. Prevalence and risk factors of gastroesophageal reflux symptoms in Chinese retiree cohort / T. Chen, M. Lu, X. Wang [et al.] // BMC Gastroenterol. – 2012. – V.12 (161).doi: 10.1186/1471-230X-12-161.
11. Role of body composition and metabolic profile in Barrett’s oesophagus and progression to cancer / S. Di Caro, W.H. Cheung, L. Fini [et al.] // Eur J Gastroenterol Hepatol. – 2016. – V. 28(3). – P.251–260. doi: 10.1097/MEG.0000000000000536.
Review
For citations:
Asekritova A.S., Kylbanova E.S. Comorbidity of clinical symptoms of reflux disease with lipid-metabolic parameters in Yakuts. Yakut Medical Journal. 2019;(1):76-79. https://doi.org/2510.25789/YMJ.2019.65.24